Dergiler / Turkish Journal of Gastroenterology / 2020 / Cilt: 31 - Sayı: 2

The Role of 18F-FDG PET/CT in staging of gallbladder carcinomas

Sayfa
105–112
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In addition, we believe that 18F-FDG PET/CT imaging will help to stage the GBC, detect nodal and distant metastasis, and evaluate the metabolic state of gallbladder lesions.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aims: Gallbladder Carcinoma (GBC) is the most common and aggressive tumor of the biliary tract.
📊
Temel Bulgular & Veri:In our study, we aimed to demonstrate the uptake patterns of 18F-FDG PET/CT in GBC, as well as its association with survival and diagnostic value during the initial stage.Materials and Methods: Overall, 17 patients with GBC were retrospectively included in the study. 18F-FDG PET/CT study was performed for pretreatment staging.
💡
Sonuç & Katkı:In addition, we believe that 18F-FDG PET/CT imaging will help to stage the GBC, detect nodal and distant metastasis, and evaluate the metabolic state of gallbladder lesions.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Background/Aims: Gallbladder Carcinoma (GBC) is the most common and aggressive tumor of the biliary tract. Patients are typically diagnosed during advanced stages, and the mean overall survival is short. In our study, we aimed to demonstrate the uptake patterns of 18F-FDG PET/CT in GBC, as well as its association with survival and diagnostic value during the initial stage.Materials and Methods: Overall, 17 patients with GBC were retrospectively included in the study. 18F-FDG PET/CT study was performed for pretreatment staging. Two different standardized uptake values (SUVmax and SUVmean), metabolic tumor volume 40% (MTV40), and tumor lesion glycolysis (TLG) of the primary tumors were compared between the clinical and histopathological groups.Results: Of the 17 patients, 11 were women (64.7%), and 6 (35.3%) were men. The mean age of the patients was 69.7±8.8 years. 18F-FDG uptake was detected in all lesions. Mean SUVmax was calculated to be 15.4±13.7 (median=10.6, range=3.4-46.8). All distant metastases (52.9%) were detected in the liver. Semiquantitative metabolic parameters (SUVmax and SUVmean, MTV40, and TLG) obtained from patients with distant metastasis were not significantly higher than those without distant metastasis. Similar results were obtained in patients with and without nodal metastasis. No statistically significant intergroup difference was observed regarding metabolic parameters. However, a statistically significant negative correlation was observed between the patient’s age and the SUVmax of the primary lesion and metastatic lymph nodes (r=−0.564, p=0.018). During 10.7±10.4 months of mean follow-up, the mean survival of patients with distant metastases (6.1±11.0 months) was significantly shorter than that of patients with no organ metastases (15.8±7.1 months).Conclusion: In our study, distant metastases and age were observed to be crucial prognostic factors in patients with gallbladder carcinoma (GBC). In addition, we believe that 18F-FDG PET/CT imaging will help to stage the GBC, detect nodal and distant metastasis, and evaluate the metabolic state of gallbladder lesions.

🔖

Bu Makaleye Atıf Yap

ARSLAN, E., AKSOY, T., DURSUN, N., GÜRSU, R. U., SEVİNÇ, M. M., ÇERMİK, T. F. (2020). The Role of 18F-FDG PET/CT in staging of gallbladder carcinomas. Turkish Journal of Gastroenterology, Cilt: 31 - Sayı: 2, 105–112. https://ajindex.com/articles/410024

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update. World J Gastroenterol 2017; 23: 3978-98
  2. Jaruvongvanich V, Yang JD, Peeraphatdit T, Roberts LR. The in cidence rates and survival of gallbladder cancer in the USA. Eur J Cancer Prev 2019; 28: 1-9
  3. Kanthan R, Senger JL, Ahmed S, Kanthan SC. Gallbladder cancer in the 21st century. J Oncol 2015; 2015: 967472
  4. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and out come. Clin Epidemiol 2014; 6: 99-109
  5. Kumar R, Sharma P, Kumari A, Halanaik D, Malhotra A. Role of 18F-FDG PET/CT in detecting recurrent gallbladder carcinoma. Clin Nucl Med 2012; 37: 431-5
  6. Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist 2010; 15: 168-81
  7. Ma KW, Cheung TT, She WH, et al. Diagnostic and prognostic role of 18-FDG PET/CT in the management of resectable biliary tract cancer. World J Surg 2018; 42: 823-34
  8. Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging hand book: From the AJCC cancer staging manual. 2010; 7th ed. Springer
  9. Toba T, Kijima H, Hakamada K, Igarashi Y. Histological phenotype is correlated with the wall-invasion pattern of gallbladder adenocar cinoma. Biomed Res 2014; 35: 295-302
  10. Park MS, Lee SM. Preoperative 18F-FDG PET-CT maximum stan dardized uptake value predicts recurrence of biliary tract cancer. An ticancer Res 2014; 34: 2551-4
  11. Koh T, Taniguchi H, Yamaguchi A, Kunishima S, Yamagishi H. Dif ferential diagnosis of gallbladder cancer using positron emission to mography with fluorine-18-labeled fluoro-deoxyglucose (FDG-PET). J Surg Oncol 2003; 84: 74-81
  12. Zimmermann A. Adenocarcinoma of the Gallbladder: Biology of Disease, Prognosticators, and Staging. Tumors and Tumor-Like Le sions of the Hepatobiliary Tract. 2016; pp.1-24
  13. Ramos-Font C, Gómez-Rio M, Rodríguez-Fernández A, Jiménez-Heffernan A, Sánchez RS, Llamas-Elvira JM. Ability of FDG PET/CT in the detection of gallbladder cancer. J Surg Oncol 2014; 109: 218-24
  14. Hu JH, Tang JH, Lin CH, Chu YY, Liu NJ. Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxy glucose positron emission tomography: a meta-analysis. J Investig Med 2018; 66: 52-61
  15. Lee SW, Kim HJ, Park JH, et al. Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcino ma. J Gastroenterol 2010; 45: 560-6
  16. Ramos-Font C, Río MG, Rodríguez-Fernánd